Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French‐Canadian families with high risk of breast and ovarian cancer
Simard, J., […] Joly, Y., et al., “Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French‐Canadian families with high risk of breast and ovarian cancer” 44:2 (2007) Journal of Medical Genetics, 107-121.
Ce contenu a été mis à jour le 25 juillet 2019 à 11 h 20 min.